Combination of Multiple Low-Risk Lifestyle Behaviors and Incident Type 2 Diabetes : A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies
© 2023 by the American Diabetes Association..
OBJECTIVE: Combined low-risk lifestyle behaviors (LRLBs) have been associated with a reduction in type 2 diabetes risk. This relationship has not been systematically quantified.
RESEARCH DESIGN AND METHODS: A systematic review and meta-analysis was conducted to assess the association of combined LRLBs with type 2 diabetes. Databases were searched up to September 2022. Prospective cohort studies reporting the association between a minimum of three combined LRLBs (including healthy diet) with incident type 2 diabetes were included. Independent reviewers extracted data and assessed study quality. Risk estimates of extreme comparisons were pooled using a random-effects model. Global dose-response meta-analysis (DRM) for maximum adherence was estimated using a one-stage linear mixed model. The certainty of the evidence was assessed using GRADE (Grading of Recommendations, Assessment, Development and Evaluations).
RESULTS: Thirty cohort comparisons (n = 1,693,753) involving 75,669 incident type 2 diabetes cases were included. LRLBs, with author-defined ranges, were healthy body weight, healthy diet, regular exercise, smoking abstinence or cessation, and light alcohol consumption. LRLBs were associated with 80% lower risk of type 2 diabetes (relative risk [RR] 0.20; 95% CI 0.17-0.23), comparing the highest with lowest adherence. Global DRM for maximum adherence to all five LRLBs reached 85% protection (RR 0.15; 95% CI 0.12-0.18). The overall certainty of the evidence was graded as high.
CONCLUSIONS: There is a very good indication that a combination of LRLBs that includes maintaining a healthy bodyweight, healthy diet, regular exercise, smoking abstinence or cessation, and light alcohol consumption is associated with a lower risk of incident type 2 diabetes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
---|---|
Enthalten in: |
Diabetes care - 46(2023), 3 vom: 01. März, Seite 643-656 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Khan, Tauseef A [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 24.02.2023 Date Revised 22.08.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.2337/dc22-1024 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM353186953 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM353186953 | ||
003 | DE-627 | ||
005 | 20231226055430.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2337/dc22-1024 |2 doi | |
028 | 5 | 2 | |a pubmed24n1177.xml |
035 | |a (DE-627)NLM353186953 | ||
035 | |a (NLM)36812419 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Khan, Tauseef A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Combination of Multiple Low-Risk Lifestyle Behaviors and Incident Type 2 Diabetes |b A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.02.2023 | ||
500 | |a Date Revised 22.08.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 by the American Diabetes Association. | ||
520 | |a OBJECTIVE: Combined low-risk lifestyle behaviors (LRLBs) have been associated with a reduction in type 2 diabetes risk. This relationship has not been systematically quantified | ||
520 | |a RESEARCH DESIGN AND METHODS: A systematic review and meta-analysis was conducted to assess the association of combined LRLBs with type 2 diabetes. Databases were searched up to September 2022. Prospective cohort studies reporting the association between a minimum of three combined LRLBs (including healthy diet) with incident type 2 diabetes were included. Independent reviewers extracted data and assessed study quality. Risk estimates of extreme comparisons were pooled using a random-effects model. Global dose-response meta-analysis (DRM) for maximum adherence was estimated using a one-stage linear mixed model. The certainty of the evidence was assessed using GRADE (Grading of Recommendations, Assessment, Development and Evaluations) | ||
520 | |a RESULTS: Thirty cohort comparisons (n = 1,693,753) involving 75,669 incident type 2 diabetes cases were included. LRLBs, with author-defined ranges, were healthy body weight, healthy diet, regular exercise, smoking abstinence or cessation, and light alcohol consumption. LRLBs were associated with 80% lower risk of type 2 diabetes (relative risk [RR] 0.20; 95% CI 0.17-0.23), comparing the highest with lowest adherence. Global DRM for maximum adherence to all five LRLBs reached 85% protection (RR 0.15; 95% CI 0.12-0.18). The overall certainty of the evidence was graded as high | ||
520 | |a CONCLUSIONS: There is a very good indication that a combination of LRLBs that includes maintaining a healthy bodyweight, healthy diet, regular exercise, smoking abstinence or cessation, and light alcohol consumption is associated with a lower risk of incident type 2 diabetes | ||
650 | 4 | |a Systematic Review | |
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
700 | 1 | |a Field, David |e verfasserin |4 aut | |
700 | 1 | |a Chen, Victoria |e verfasserin |4 aut | |
700 | 1 | |a Ahmad, Suleman |e verfasserin |4 aut | |
700 | 1 | |a Mejia, Sonia Blanco |e verfasserin |4 aut | |
700 | 1 | |a Kahleová, Hana |e verfasserin |4 aut | |
700 | 1 | |a Rahelić, Dario |e verfasserin |4 aut | |
700 | 1 | |a Salas-Salvadó, Jordi |e verfasserin |4 aut | |
700 | 1 | |a Leiter, Lawrence A |e verfasserin |4 aut | |
700 | 1 | |a Uusitupa, Matti |e verfasserin |4 aut | |
700 | 1 | |a Kendall, Cyril W C |e verfasserin |4 aut | |
700 | 1 | |a Sievenpiper, John L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetes care |d 1979 |g 46(2023), 3 vom: 01. März, Seite 643-656 |w (DE-627)NLM00042983X |x 1935-5548 |7 nnns |
773 | 1 | 8 | |g volume:46 |g year:2023 |g number:3 |g day:01 |g month:03 |g pages:643-656 |
856 | 4 | 0 | |u http://dx.doi.org/10.2337/dc22-1024 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 46 |j 2023 |e 3 |b 01 |c 03 |h 643-656 |